nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP2C9—brain cancer	0.466	1	CbGaD
Nortriptyline—CYP2D6—Lomustine—brain cancer	0.0446	0.163	CbGbCtD
Nortriptyline—CYP1A2—Carmustine—brain cancer	0.0442	0.161	CbGbCtD
Nortriptyline—CYP2D6—Hydroxyurea—brain cancer	0.0338	0.124	CbGbCtD
Nortriptyline—CYP3A4—Temozolomide—brain cancer	0.0334	0.122	CbGbCtD
Nortriptyline—PTGS1—Etoposide—brain cancer	0.0293	0.107	CbGbCtD
Nortriptyline—CYP3A4—Lomustine—brain cancer	0.0284	0.104	CbGbCtD
Nortriptyline—CYP2E1—Etoposide—brain cancer	0.0226	0.0826	CbGbCtD
Nortriptyline—CYP3A5—Etoposide—brain cancer	0.0176	0.0642	CbGbCtD
Nortriptyline—CYP1A2—Etoposide—brain cancer	0.0131	0.0478	CbGbCtD
Nortriptyline—HTR2C—choroid plexus—brain cancer	0.00776	0.0863	CbGeAlD
Nortriptyline—CYP3A4—Etoposide—brain cancer	0.00686	0.025	CbGbCtD
Nortriptyline—HTR2A—choroid plexus—brain cancer	0.00389	0.0433	CbGeAlD
Nortriptyline—HRH1—nose—brain cancer	0.00301	0.0334	CbGeAlD
Nortriptyline—HTR6—ganglion—brain cancer	0.00245	0.0272	CbGeAlD
Nortriptyline—HTR2C—telencephalic ventricle—brain cancer	0.00227	0.0253	CbGeAlD
Nortriptyline—HTR2A—trigeminal nerve—brain cancer	0.00197	0.0219	CbGeAlD
Nortriptyline—HTR2A—cerebellar cortex—brain cancer	0.00196	0.0218	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—brain cancer	0.00191	0.0213	CbGeAlD
Nortriptyline—HTR2A—vein—brain cancer	0.00178	0.0198	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—brain cancer	0.00173	0.0192	CbGeAlD
Nortriptyline—HTR2C—ganglion—brain cancer	0.00142	0.0157	CbGeAlD
Nortriptyline—HTR2A—cranial nerve—brain cancer	0.0014	0.0156	CbGeAlD
Nortriptyline—HTR2A—pons—brain cancer	0.00139	0.0154	CbGeAlD
Nortriptyline—SLC6A4—ganglion—brain cancer	0.00134	0.0149	CbGeAlD
Nortriptyline—HTR1A—ganglion—brain cancer	0.00119	0.0132	CbGeAlD
Nortriptyline—SLC6A2—ganglion—brain cancer	0.00118	0.0131	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—brain cancer	0.00114	0.0127	CbGeAlD
Nortriptyline—DRD2—ganglion—brain cancer	0.00108	0.012	CbGeAlD
Nortriptyline—SLC6A4—hindbrain—brain cancer	0.00102	0.0113	CbGeAlD
Nortriptyline—HTR2A—pineal body—brain cancer	0.00099	0.011	CbGeAlD
Nortriptyline—HTR6—telencephalon—brain cancer	0.000945	0.0105	CbGeAlD
Nortriptyline—Purpura—Procarbazine—brain cancer	0.000916	0.00793	CcSEcCtD
Nortriptyline—HTR1A—hindbrain—brain cancer	0.000904	0.01	CbGeAlD
Nortriptyline—Petechiae—Temozolomide—brain cancer	0.000894	0.00774	CcSEcCtD
Nortriptyline—Alopecia—Lomustine—brain cancer	0.00085	0.00736	CcSEcCtD
Nortriptyline—ADRA1A—hindbrain—brain cancer	0.000833	0.00926	CbGeAlD
Nortriptyline—Ataxia—Procarbazine—brain cancer	0.00083	0.00719	CcSEcCtD
Nortriptyline—DRD2—hindbrain—brain cancer	0.000817	0.00908	CbGeAlD
Nortriptyline—PTGS1—ganglion—brain cancer	0.000787	0.00875	CbGeAlD
Nortriptyline—Coordination abnormal—Carmustine—brain cancer	0.000775	0.00671	CcSEcCtD
Nortriptyline—Disorientation—Hydroxyurea—brain cancer	0.000764	0.00661	CcSEcCtD
Nortriptyline—Eosinophilia—Procarbazine—brain cancer	0.000756	0.00654	CcSEcCtD
Nortriptyline—Leukopenia—Lomustine—brain cancer	0.00075	0.00649	CcSEcCtD
Nortriptyline—Coordination abnormal—Temozolomide—brain cancer	0.000749	0.00648	CcSEcCtD
Nortriptyline—Sweating increased—Procarbazine—brain cancer	0.000743	0.00644	CcSEcCtD
Nortriptyline—ADRA1D—telencephalon—brain cancer	0.000738	0.0082	CbGeAlD
Nortriptyline—Tingling sensation—Etoposide—brain cancer	0.000732	0.00634	CcSEcCtD
Nortriptyline—Pancytopenia—Procarbazine—brain cancer	0.000725	0.00628	CcSEcCtD
Nortriptyline—HTR2A—ganglion—brain cancer	0.00071	0.00789	CbGeAlD
Nortriptyline—Numbness—Etoposide—brain cancer	0.00071	0.00615	CcSEcCtD
Nortriptyline—Pollakiuria—Procarbazine—brain cancer	0.000705	0.0061	CcSEcCtD
Nortriptyline—Aplastic anaemia—Temozolomide—brain cancer	0.000691	0.00598	CcSEcCtD
Nortriptyline—Gynaecomastia—Carmustine—brain cancer	0.000681	0.0059	CcSEcCtD
Nortriptyline—Drowsiness—Procarbazine—brain cancer	0.000681	0.00589	CcSEcCtD
Nortriptyline—Sensory loss—Etoposide—brain cancer	0.000679	0.00588	CcSEcCtD
Nortriptyline—PTGS1—endothelium—brain cancer	0.000679	0.00755	CbGeAlD
Nortriptyline—Thrombocytopenia—Lomustine—brain cancer	0.000669	0.00579	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Procarbazine—brain cancer	0.000667	0.00578	CcSEcCtD
Nortriptyline—Stomatitis—Procarbazine—brain cancer	0.000663	0.00574	CcSEcCtD
Nortriptyline—Jaundice—Procarbazine—brain cancer	0.000663	0.00574	CcSEcCtD
Nortriptyline—CHRM4—head—brain cancer	0.000658	0.00731	CbGeAlD
Nortriptyline—Sweating—Procarbazine—brain cancer	0.000652	0.00565	CcSEcCtD
Nortriptyline—Anorexia—Lomustine—brain cancer	0.000652	0.00564	CcSEcCtD
Nortriptyline—PTGS1—blood vessel—brain cancer	0.000626	0.00696	CbGeAlD
Nortriptyline—Body temperature increased—Carboplatin—brain cancer	0.000618	0.00535	CcSEcCtD
Nortriptyline—HTR2C—brainstem—brain cancer	0.000615	0.00684	CbGeAlD
Nortriptyline—HTR2A—endothelium—brain cancer	0.000612	0.00681	CbGeAlD
Nortriptyline—Eye pain—Carmustine—brain cancer	0.000612	0.0053	CcSEcCtD
Nortriptyline—Hallucination—Procarbazine—brain cancer	0.000608	0.00526	CcSEcCtD
Nortriptyline—CHRM4—central nervous system—brain cancer	0.0006	0.00667	CbGeAlD
Nortriptyline—Vascular purpura—Temozolomide—brain cancer	0.000597	0.00517	CcSEcCtD
Nortriptyline—Decreased appetite—Lomustine—brain cancer	0.000594	0.00514	CcSEcCtD
Nortriptyline—Eye pain—Temozolomide—brain cancer	0.000591	0.00512	CcSEcCtD
Nortriptyline—HTR6—head—brain cancer	0.000589	0.00654	CbGeAlD
Nortriptyline—SLC6A4—brainstem—brain cancer	0.000583	0.00649	CbGeAlD
Nortriptyline—Hot flush—Temozolomide—brain cancer	0.000571	0.00494	CcSEcCtD
Nortriptyline—Flushing—Procarbazine—brain cancer	0.000567	0.00491	CcSEcCtD
Nortriptyline—CHRM2—telencephalon—brain cancer	0.000567	0.0063	CbGeAlD
Nortriptyline—Menopausal symptoms—Temozolomide—brain cancer	0.000566	0.0049	CcSEcCtD
Nortriptyline—HTR2A—blood vessel—brain cancer	0.000565	0.00628	CbGeAlD
Nortriptyline—Pancytopenia—Hydroxyurea—brain cancer	0.000561	0.00486	CcSEcCtD
Nortriptyline—Purpura—Temozolomide—brain cancer	0.000554	0.0048	CcSEcCtD
Nortriptyline—HTR2C—telencephalon—brain cancer	0.000546	0.00607	CbGeAlD
Nortriptyline—Arrhythmia—Procarbazine—brain cancer	0.000546	0.00472	CcSEcCtD
Nortriptyline—Body temperature increased—Lomustine—brain cancer	0.00054	0.00468	CcSEcCtD
Nortriptyline—Alopecia—Procarbazine—brain cancer	0.00054	0.00467	CcSEcCtD
Nortriptyline—HTR2A—hindbrain—brain cancer	0.000539	0.00599	CbGeAlD
Nortriptyline—Weight increased—Hydroxyurea—brain cancer	0.000538	0.00465	CcSEcCtD
Nortriptyline—HTR6—central nervous system—brain cancer	0.000537	0.00597	CbGeAlD
Nortriptyline—Drowsiness—Hydroxyurea—brain cancer	0.000527	0.00456	CcSEcCtD
Nortriptyline—Tension—Procarbazine—brain cancer	0.000522	0.00452	CcSEcCtD
Nortriptyline—Ataxia—Carmustine—brain cancer	0.00052	0.0045	CcSEcCtD
Nortriptyline—HTR1A—brainstem—brain cancer	0.000518	0.00576	CbGeAlD
Nortriptyline—SLC6A4—telencephalon—brain cancer	0.000518	0.00576	CbGeAlD
Nortriptyline—Nervousness—Procarbazine—brain cancer	0.000517	0.00447	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000516	0.00447	CcSEcCtD
Nortriptyline—CHRM1—telencephalon—brain cancer	0.000516	0.00573	CbGeAlD
Nortriptyline—CHRM5—head—brain cancer	0.000514	0.00571	CbGeAlD
Nortriptyline—SLC6A2—brainstem—brain cancer	0.000514	0.00571	CbGeAlD
Nortriptyline—Stomatitis—Hydroxyurea—brain cancer	0.000513	0.00444	CcSEcCtD
Nortriptyline—Ataxia—Temozolomide—brain cancer	0.000502	0.00435	CcSEcCtD
Nortriptyline—Tremor—Procarbazine—brain cancer	0.000498	0.00431	CcSEcCtD
Nortriptyline—CYP2D6—hindbrain—brain cancer	0.000491	0.00545	CbGeAlD
Nortriptyline—ADRA1A—brainstem—brain cancer	0.000478	0.00531	CbGeAlD
Nortriptyline—Syncope—Procarbazine—brain cancer	0.000477	0.00413	CcSEcCtD
Nortriptyline—CHRM4—brain—brain cancer	0.000477	0.0053	CbGeAlD
Nortriptyline—Leukopenia—Procarbazine—brain cancer	0.000476	0.00412	CcSEcCtD
Nortriptyline—Hallucination—Hydroxyurea—brain cancer	0.00047	0.00407	CcSEcCtD
Nortriptyline—ADRA1B—head—brain cancer	0.00047	0.00522	CbGeAlD
Nortriptyline—CHRM5—central nervous system—brain cancer	0.000469	0.00522	CbGeAlD
Nortriptyline—DRD2—brainstem—brain cancer	0.000468	0.0052	CbGeAlD
Nortriptyline—Loss of consciousness—Procarbazine—brain cancer	0.000467	0.00405	CcSEcCtD
Nortriptyline—ADRA1D—endocrine gland—brain cancer	0.000465	0.00517	CbGeAlD
Nortriptyline—CHRM3—telencephalon—brain cancer	0.000462	0.00513	CbGeAlD
Nortriptyline—Convulsion—Procarbazine—brain cancer	0.000461	0.00399	CcSEcCtD
Nortriptyline—HTR1A—telencephalon—brain cancer	0.00046	0.00511	CbGeAlD
Nortriptyline—ADRA1D—head—brain cancer	0.000459	0.00511	CbGeAlD
Nortriptyline—Hypertension—Procarbazine—brain cancer	0.000459	0.00398	CcSEcCtD
Nortriptyline—SLC6A2—telencephalon—brain cancer	0.000456	0.00507	CbGeAlD
Nortriptyline—Pancytopenia—Carmustine—brain cancer	0.000453	0.00393	CcSEcCtD
Nortriptyline—Anxiety—Procarbazine—brain cancer	0.000451	0.00391	CcSEcCtD
Nortriptyline—Sweating increased—Temozolomide—brain cancer	0.00045	0.00389	CcSEcCtD
Nortriptyline—Dry mouth—Procarbazine—brain cancer	0.000443	0.00383	CcSEcCtD
Nortriptyline—Pancytopenia—Temozolomide—brain cancer	0.000438	0.00379	CcSEcCtD
Nortriptyline—Confusional state—Procarbazine—brain cancer	0.000438	0.00379	CcSEcCtD
Nortriptyline—Vomiting—Lomustine—brain cancer	0.000435	0.00376	CcSEcCtD
Nortriptyline—Oedema—Procarbazine—brain cancer	0.000434	0.00376	CcSEcCtD
Nortriptyline—HTR2C—medulla oblongata—brain cancer	0.000429	0.00477	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—brain cancer	0.000429	0.00477	CbGeAlD
Nortriptyline—Shock—Procarbazine—brain cancer	0.000427	0.0037	CcSEcCtD
Nortriptyline—HTR6—brain—brain cancer	0.000427	0.00474	CbGeAlD
Nortriptyline—Pollakiuria—Temozolomide—brain cancer	0.000426	0.00369	CcSEcCtD
Nortriptyline—ORM1—spinal cord—brain cancer	0.000426	0.00473	CbGeAlD
Nortriptyline—Erectile dysfunction—Temozolomide—brain cancer	0.000425	0.00368	CcSEcCtD
Nortriptyline—Thrombocytopenia—Procarbazine—brain cancer	0.000425	0.00368	CcSEcCtD
Nortriptyline—ADRA1A—telencephalon—brain cancer	0.000424	0.00471	CbGeAlD
Nortriptyline—Tachycardia—Procarbazine—brain cancer	0.000424	0.00367	CcSEcCtD
Nortriptyline—Weight increased—Temozolomide—brain cancer	0.00042	0.00364	CcSEcCtD
Nortriptyline—Hyperhidrosis—Procarbazine—brain cancer	0.00042	0.00363	CcSEcCtD
Nortriptyline—ADRA1D—central nervous system—brain cancer	0.000419	0.00466	CbGeAlD
Nortriptyline—Alopecia—Hydroxyurea—brain cancer	0.000418	0.00362	CcSEcCtD
Nortriptyline—Weight decreased—Temozolomide—brain cancer	0.000417	0.00361	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Carmustine—brain cancer	0.000417	0.00361	CcSEcCtD
Nortriptyline—DRD2—telencephalon—brain cancer	0.000415	0.00462	CbGeAlD
Nortriptyline—Stomatitis—Carmustine—brain cancer	0.000415	0.00359	CcSEcCtD
Nortriptyline—Anorexia—Procarbazine—brain cancer	0.000414	0.00358	CcSEcCtD
Nortriptyline—Nausea—Lomustine—brain cancer	0.000406	0.00352	CcSEcCtD
Nortriptyline—Hypotension—Procarbazine—brain cancer	0.000406	0.00351	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Temozolomide—brain cancer	0.000403	0.00349	CcSEcCtD
Nortriptyline—Stomatitis—Temozolomide—brain cancer	0.000401	0.00347	CcSEcCtD
Nortriptyline—Insomnia—Procarbazine—brain cancer	0.000393	0.0034	CcSEcCtD
Nortriptyline—HTR2C—midbrain—brain cancer	0.000392	0.00436	CbGeAlD
Nortriptyline—Paraesthesia—Procarbazine—brain cancer	0.00039	0.00337	CcSEcCtD
Nortriptyline—Somnolence—Procarbazine—brain cancer	0.000386	0.00334	CcSEcCtD
Nortriptyline—ORM1—endocrine gland—brain cancer	0.000383	0.00426	CbGeAlD
Nortriptyline—HTR2C—spinal cord—brain cancer	0.000383	0.00425	CbGeAlD
Nortriptyline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000382	0.00331	CcSEcCtD
Nortriptyline—SLC6A2—gonad—brain cancer	0.00038	0.00423	CbGeAlD
Nortriptyline—Hypoaesthesia—Carmustine—brain cancer	0.00038	0.00329	CcSEcCtD
Nortriptyline—Hallucination—Carmustine—brain cancer	0.00038	0.00329	CcSEcCtD
Nortriptyline—Decreased appetite—Procarbazine—brain cancer	0.000377	0.00327	CcSEcCtD
Nortriptyline—Oedema peripheral—Carmustine—brain cancer	0.000377	0.00326	CcSEcCtD
Nortriptyline—Fatigue—Procarbazine—brain cancer	0.000374	0.00324	CcSEcCtD
Nortriptyline—CHRM5—brain—brain cancer	0.000373	0.00414	CbGeAlD
Nortriptyline—SLC6A4—midbrain—brain cancer	0.000372	0.00413	CbGeAlD
Nortriptyline—Malaise—Hydroxyurea—brain cancer	0.000371	0.00321	CcSEcCtD
Nortriptyline—Constipation—Procarbazine—brain cancer	0.000371	0.00321	CcSEcCtD
Nortriptyline—Hepatitis—Temozolomide—brain cancer	0.000369	0.0032	CcSEcCtD
Nortriptyline—Leukopenia—Hydroxyurea—brain cancer	0.000368	0.00319	CcSEcCtD
Nortriptyline—Hypoaesthesia—Temozolomide—brain cancer	0.000368	0.00318	CcSEcCtD
Nortriptyline—Hallucination—Temozolomide—brain cancer	0.000368	0.00318	CcSEcCtD
Nortriptyline—Oedema peripheral—Temozolomide—brain cancer	0.000364	0.00315	CcSEcCtD
Nortriptyline—SLC6A4—spinal cord—brain cancer	0.000363	0.00403	CbGeAlD
Nortriptyline—Sweating increased—Etoposide—brain cancer	0.00036	0.00311	CcSEcCtD
Nortriptyline—SLC6A2—medulla oblongata—brain cancer	0.000358	0.00398	CbGeAlD
Nortriptyline—Feeling abnormal—Procarbazine—brain cancer	0.000358	0.0031	CcSEcCtD
Nortriptyline—CHRM2—endocrine gland—brain cancer	0.000357	0.00397	CbGeAlD
Nortriptyline—Eye disorder—Carmustine—brain cancer	0.000357	0.00309	CcSEcCtD
Nortriptyline—Convulsion—Hydroxyurea—brain cancer	0.000357	0.00309	CcSEcCtD
Nortriptyline—Flushing—Carmustine—brain cancer	0.000355	0.00307	CcSEcCtD
Nortriptyline—CHRM2—head—brain cancer	0.000353	0.00392	CbGeAlD
Nortriptyline—Pancytopenia—Etoposide—brain cancer	0.000351	0.00304	CcSEcCtD
Nortriptyline—Discomfort—Hydroxyurea—brain cancer	0.000346	0.003	CcSEcCtD
Nortriptyline—ORM1—central nervous system—brain cancer	0.000345	0.00384	CbGeAlD
Nortriptyline—Eye disorder—Temozolomide—brain cancer	0.000345	0.00299	CcSEcCtD
Nortriptyline—Urticaria—Procarbazine—brain cancer	0.000345	0.00299	CcSEcCtD
Nortriptyline—Tinnitus—Temozolomide—brain cancer	0.000344	0.00298	CcSEcCtD
Nortriptyline—Abdominal pain—Procarbazine—brain cancer	0.000343	0.00297	CcSEcCtD
Nortriptyline—Body temperature increased—Procarbazine—brain cancer	0.000343	0.00297	CcSEcCtD
Nortriptyline—Flushing—Temozolomide—brain cancer	0.000343	0.00297	CcSEcCtD
Nortriptyline—Arrhythmia—Carmustine—brain cancer	0.000341	0.00296	CcSEcCtD
Nortriptyline—ADRA1B—brain—brain cancer	0.00034	0.00378	CbGeAlD
Nortriptyline—HTR2C—head—brain cancer	0.00034	0.00378	CbGeAlD
Nortriptyline—DRD2—pituitary gland—brain cancer	0.000338	0.00376	CbGeAlD
Nortriptyline—Alopecia—Carmustine—brain cancer	0.000338	0.00292	CcSEcCtD
Nortriptyline—Oedema—Hydroxyurea—brain cancer	0.000336	0.00291	CcSEcCtD
Nortriptyline—ADRA1D—brain—brain cancer	0.000333	0.0037	CbGeAlD
Nortriptyline—HTR1A—midbrain—brain cancer	0.00033	0.00367	CbGeAlD
Nortriptyline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000329	0.00285	CcSEcCtD
Nortriptyline—HRH1—telencephalon—brain cancer	0.000328	0.00365	CbGeAlD
Nortriptyline—SLC6A4—endocrine gland—brain cancer	0.000327	0.00363	CbGeAlD
Nortriptyline—Alopecia—Temozolomide—brain cancer	0.000326	0.00283	CcSEcCtD
Nortriptyline—CHRM1—endocrine gland—brain cancer	0.000325	0.00362	CbGeAlD
Nortriptyline—Acute coronary syndrome—Etoposide—brain cancer	0.000325	0.00281	CcSEcCtD
Nortriptyline—Myocardial infarction—Etoposide—brain cancer	0.000323	0.00279	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Etoposide—brain cancer	0.000323	0.00279	CcSEcCtD
Nortriptyline—SLC6A4—head—brain cancer	0.000322	0.00358	CbGeAlD
Nortriptyline—HTR1A—spinal cord—brain cancer	0.000322	0.00358	CbGeAlD
Nortriptyline—CHRM2—central nervous system—brain cancer	0.000322	0.00358	CbGeAlD
Nortriptyline—CHRM1—head—brain cancer	0.000321	0.00357	CbGeAlD
Nortriptyline—Stomatitis—Etoposide—brain cancer	0.000321	0.00278	CcSEcCtD
Nortriptyline—Jaundice—Etoposide—brain cancer	0.000321	0.00278	CcSEcCtD
Nortriptyline—Anorexia—Hydroxyurea—brain cancer	0.00032	0.00277	CcSEcCtD
Nortriptyline—Hypersensitivity—Procarbazine—brain cancer	0.00032	0.00277	CcSEcCtD
Nortriptyline—CYP2E1—telencephalon—brain cancer	0.000315	0.0035	CbGeAlD
Nortriptyline—Dysgeusia—Temozolomide—brain cancer	0.000315	0.00273	CcSEcCtD
Nortriptyline—Vision blurred—Carmustine—brain cancer	0.000314	0.00271	CcSEcCtD
Nortriptyline—Tremor—Carmustine—brain cancer	0.000312	0.0027	CcSEcCtD
Nortriptyline—Asthenia—Procarbazine—brain cancer	0.000311	0.0027	CcSEcCtD
Nortriptyline—HTR2C—central nervous system—brain cancer	0.00031	0.00345	CbGeAlD
Nortriptyline—HTR2A—brainstem—brain cancer	0.000309	0.00343	CbGeAlD
Nortriptyline—Agranulocytosis—Etoposide—brain cancer	0.000307	0.00266	CcSEcCtD
Nortriptyline—Pruritus—Procarbazine—brain cancer	0.000307	0.00266	CcSEcCtD
Nortriptyline—Agitation—Carmustine—brain cancer	0.000306	0.00265	CcSEcCtD
Nortriptyline—PTGS1—telencephalon—brain cancer	0.000304	0.00338	CbGeAlD
Nortriptyline—Vision blurred—Temozolomide—brain cancer	0.000303	0.00262	CcSEcCtD
Nortriptyline—Tremor—Temozolomide—brain cancer	0.000301	0.00261	CcSEcCtD
Nortriptyline—Somnolence—Hydroxyurea—brain cancer	0.000299	0.00259	CcSEcCtD
Nortriptyline—Ill-defined disorder—Temozolomide—brain cancer	0.000298	0.00258	CcSEcCtD
Nortriptyline—DRD2—midbrain—brain cancer	0.000298	0.00332	CbGeAlD
Nortriptyline—Leukopenia—Carmustine—brain cancer	0.000298	0.00258	CcSEcCtD
Nortriptyline—Diarrhoea—Procarbazine—brain cancer	0.000297	0.00257	CcSEcCtD
Nortriptyline—Dyspepsia—Hydroxyurea—brain cancer	0.000296	0.00256	CcSEcCtD
Nortriptyline—Agitation—Temozolomide—brain cancer	0.000295	0.00256	CcSEcCtD
Nortriptyline—SLC6A4—central nervous system—brain cancer	0.000294	0.00327	CbGeAlD
Nortriptyline—Hypoaesthesia—Etoposide—brain cancer	0.000294	0.00255	CcSEcCtD
Nortriptyline—CHRM1—central nervous system—brain cancer	0.000293	0.00326	CbGeAlD
Nortriptyline—Decreased appetite—Hydroxyurea—brain cancer	0.000292	0.00253	CcSEcCtD
Nortriptyline—CHRM3—endocrine gland—brain cancer	0.000291	0.00324	CbGeAlD
Nortriptyline—HTR1A—endocrine gland—brain cancer	0.00029	0.00322	CbGeAlD
Nortriptyline—Malaise—Temozolomide—brain cancer	0.00029	0.00251	CcSEcCtD
Nortriptyline—Fatigue—Hydroxyurea—brain cancer	0.00029	0.00251	CcSEcCtD
Nortriptyline—Convulsion—Carmustine—brain cancer	0.000288	0.0025	CcSEcCtD
Nortriptyline—Leukopenia—Temozolomide—brain cancer	0.000288	0.00249	CcSEcCtD
Nortriptyline—SLC6A2—endocrine gland—brain cancer	0.000288	0.0032	CbGeAlD
Nortriptyline—CHRM3—head—brain cancer	0.000287	0.00319	CbGeAlD
Nortriptyline—Hypertension—Carmustine—brain cancer	0.000287	0.00249	CcSEcCtD
Nortriptyline—Constipation—Hydroxyurea—brain cancer	0.000287	0.00249	CcSEcCtD
Nortriptyline—Dizziness—Procarbazine—brain cancer	0.000287	0.00248	CcSEcCtD
Nortriptyline—HTR1A—head—brain cancer	0.000286	0.00318	CbGeAlD
Nortriptyline—Palpitations—Temozolomide—brain cancer	0.000284	0.00246	CcSEcCtD
Nortriptyline—SLC6A2—head—brain cancer	0.000284	0.00316	CbGeAlD
Nortriptyline—Anxiety—Carmustine—brain cancer	0.000282	0.00244	CcSEcCtD
Nortriptyline—CYP2D6—brainstem—brain cancer	0.000281	0.00313	CbGeAlD
Nortriptyline—Convulsion—Temozolomide—brain cancer	0.000279	0.00241	CcSEcCtD
Nortriptyline—Hypertension—Temozolomide—brain cancer	0.000278	0.0024	CcSEcCtD
Nortriptyline—Feeling abnormal—Hydroxyurea—brain cancer	0.000277	0.0024	CcSEcCtD
Nortriptyline—Eye disorder—Etoposide—brain cancer	0.000276	0.00239	CcSEcCtD
Nortriptyline—Vomiting—Procarbazine—brain cancer	0.000276	0.00239	CcSEcCtD
Nortriptyline—Flushing—Etoposide—brain cancer	0.000274	0.00237	CcSEcCtD
Nortriptyline—HTR2A—telencephalon—brain cancer	0.000274	0.00305	CbGeAlD
Nortriptyline—Confusional state—Carmustine—brain cancer	0.000274	0.00237	CcSEcCtD
Nortriptyline—Rash—Procarbazine—brain cancer	0.000274	0.00237	CcSEcCtD
Nortriptyline—Dermatitis—Procarbazine—brain cancer	0.000273	0.00237	CcSEcCtD
Nortriptyline—Anxiety—Temozolomide—brain cancer	0.000273	0.00236	CcSEcCtD
Nortriptyline—Headache—Procarbazine—brain cancer	0.000272	0.00235	CcSEcCtD
Nortriptyline—Oedema—Carmustine—brain cancer	0.000272	0.00235	CcSEcCtD
Nortriptyline—CYP2C19—endocrine gland—brain cancer	0.000271	0.00301	CbGeAlD
Nortriptyline—Discomfort—Temozolomide—brain cancer	0.00027	0.00234	CcSEcCtD
Nortriptyline—Dry mouth—Temozolomide—brain cancer	0.000268	0.00232	CcSEcCtD
Nortriptyline—ADRA1A—endocrine gland—brain cancer	0.000267	0.00297	CbGeAlD
Nortriptyline—Thrombocytopenia—Carmustine—brain cancer	0.000266	0.0023	CcSEcCtD
Nortriptyline—Body temperature increased—Hydroxyurea—brain cancer	0.000266	0.0023	CcSEcCtD
Nortriptyline—Tachycardia—Carmustine—brain cancer	0.000265	0.00229	CcSEcCtD
Nortriptyline—Confusional state—Temozolomide—brain cancer	0.000265	0.00229	CcSEcCtD
Nortriptyline—ADRA1A—head—brain cancer	0.000264	0.00293	CbGeAlD
Nortriptyline—Oedema—Temozolomide—brain cancer	0.000262	0.00227	CcSEcCtD
Nortriptyline—CHRM3—central nervous system—brain cancer	0.000262	0.00292	CbGeAlD
Nortriptyline—DRD2—endocrine gland—brain cancer	0.000262	0.00291	CbGeAlD
Nortriptyline—HTR1A—central nervous system—brain cancer	0.000261	0.0029	CbGeAlD
Nortriptyline—Alopecia—Etoposide—brain cancer	0.000261	0.00226	CcSEcCtD
Nortriptyline—SLC6A2—central nervous system—brain cancer	0.000259	0.00288	CbGeAlD
Nortriptyline—Anorexia—Carmustine—brain cancer	0.000259	0.00224	CcSEcCtD
Nortriptyline—DRD2—head—brain cancer	0.000259	0.00288	CbGeAlD
Nortriptyline—Nausea—Procarbazine—brain cancer	0.000258	0.00223	CcSEcCtD
Nortriptyline—Thrombocytopenia—Temozolomide—brain cancer	0.000257	0.00222	CcSEcCtD
Nortriptyline—CHRM2—brain—brain cancer	0.000256	0.00284	CbGeAlD
Nortriptyline—HTR1A—cerebellum—brain cancer	0.000255	0.00284	CbGeAlD
Nortriptyline—Hypotension—Carmustine—brain cancer	0.000254	0.0022	CcSEcCtD
Nortriptyline—Hyperhidrosis—Temozolomide—brain cancer	0.000254	0.0022	CcSEcCtD
Nortriptyline—Dysgeusia—Etoposide—brain cancer	0.000252	0.00218	CcSEcCtD
Nortriptyline—Anorexia—Temozolomide—brain cancer	0.00025	0.00217	CcSEcCtD
Nortriptyline—CYP2D6—telencephalon—brain cancer	0.00025	0.00277	CbGeAlD
Nortriptyline—CYP2E1—medulla oblongata—brain cancer	0.000248	0.00275	CbGeAlD
Nortriptyline—Hypersensitivity—Hydroxyurea—brain cancer	0.000247	0.00214	CcSEcCtD
Nortriptyline—PTGS1—pituitary gland—brain cancer	0.000247	0.00275	CbGeAlD
Nortriptyline—HTR2C—brain—brain cancer	0.000246	0.00274	CbGeAlD
Nortriptyline—Insomnia—Carmustine—brain cancer	0.000246	0.00213	CcSEcCtD
Nortriptyline—Paraesthesia—Carmustine—brain cancer	0.000244	0.00211	CcSEcCtD
Nortriptyline—Somnolence—Carmustine—brain cancer	0.000241	0.00209	CcSEcCtD
Nortriptyline—Asthenia—Hydroxyurea—brain cancer	0.000241	0.00209	CcSEcCtD
Nortriptyline—ADRA1A—central nervous system—brain cancer	0.000241	0.00268	CbGeAlD
Nortriptyline—ALB—brain—brain cancer	0.00024	0.00267	CbGeAlD
Nortriptyline—Ill-defined disorder—Etoposide—brain cancer	0.000239	0.00207	CcSEcCtD
Nortriptyline—Insomnia—Temozolomide—brain cancer	0.000237	0.00205	CcSEcCtD
Nortriptyline—DRD2—central nervous system—brain cancer	0.000236	0.00262	CbGeAlD
Nortriptyline—Decreased appetite—Carmustine—brain cancer	0.000236	0.00204	CcSEcCtD
Nortriptyline—Paraesthesia—Temozolomide—brain cancer	0.000236	0.00204	CcSEcCtD
Nortriptyline—ADRA1A—cerebellum—brain cancer	0.000235	0.00262	CbGeAlD
Nortriptyline—SLC6A4—brain—brain cancer	0.000234	0.0026	CbGeAlD
Nortriptyline—Somnolence—Temozolomide—brain cancer	0.000233	0.00202	CcSEcCtD
Nortriptyline—CHRM1—brain—brain cancer	0.000233	0.00259	CbGeAlD
Nortriptyline—Constipation—Carmustine—brain cancer	0.000232	0.00201	CcSEcCtD
Nortriptyline—Malaise—Etoposide—brain cancer	0.000232	0.00201	CcSEcCtD
Nortriptyline—Dyspepsia—Temozolomide—brain cancer	0.000231	0.002	CcSEcCtD
Nortriptyline—DRD2—cerebellum—brain cancer	0.000231	0.00257	CbGeAlD
Nortriptyline—Leukopenia—Etoposide—brain cancer	0.00023	0.00199	CcSEcCtD
Nortriptyline—Diarrhoea—Hydroxyurea—brain cancer	0.00023	0.00199	CcSEcCtD
Nortriptyline—HTR2A—gonad—brain cancer	0.000229	0.00254	CbGeAlD
Nortriptyline—Decreased appetite—Temozolomide—brain cancer	0.000228	0.00197	CcSEcCtD
Nortriptyline—Fatigue—Temozolomide—brain cancer	0.000226	0.00196	CcSEcCtD
Nortriptyline—Loss of consciousness—Etoposide—brain cancer	0.000226	0.00196	CcSEcCtD
Nortriptyline—Constipation—Temozolomide—brain cancer	0.000224	0.00194	CcSEcCtD
Nortriptyline—Feeling abnormal—Carmustine—brain cancer	0.000224	0.00194	CcSEcCtD
Nortriptyline—HTR2A—pituitary gland—brain cancer	0.000223	0.00248	CbGeAlD
Nortriptyline—Convulsion—Etoposide—brain cancer	0.000223	0.00193	CcSEcCtD
Nortriptyline—Hypertension—Etoposide—brain cancer	0.000222	0.00192	CcSEcCtD
Nortriptyline—Dizziness—Hydroxyurea—brain cancer	0.000222	0.00192	CcSEcCtD
Nortriptyline—CYP1A2—endocrine gland—brain cancer	0.000221	0.00246	CbGeAlD
Nortriptyline—CYP2E1—spinal cord—brain cancer	0.000221	0.00246	CbGeAlD
Nortriptyline—Discomfort—Etoposide—brain cancer	0.000216	0.00187	CcSEcCtD
Nortriptyline—Feeling abnormal—Temozolomide—brain cancer	0.000216	0.00187	CcSEcCtD
Nortriptyline—HTR2A—medulla oblongata—brain cancer	0.000215	0.00239	CbGeAlD
Nortriptyline—Body temperature increased—Carmustine—brain cancer	0.000215	0.00186	CcSEcCtD
Nortriptyline—Abdominal pain—Carmustine—brain cancer	0.000215	0.00186	CcSEcCtD
Nortriptyline—Vomiting—Hydroxyurea—brain cancer	0.000214	0.00185	CcSEcCtD
Nortriptyline—CYP3A5—endocrine gland—brain cancer	0.000213	0.00237	CbGeAlD
Nortriptyline—PTGS1—spinal cord—brain cancer	0.000213	0.00237	CbGeAlD
Nortriptyline—Rash—Hydroxyurea—brain cancer	0.000212	0.00183	CcSEcCtD
Nortriptyline—Confusional state—Etoposide—brain cancer	0.000212	0.00183	CcSEcCtD
Nortriptyline—Dermatitis—Hydroxyurea—brain cancer	0.000212	0.00183	CcSEcCtD
Nortriptyline—Headache—Hydroxyurea—brain cancer	0.00021	0.00182	CcSEcCtD
Nortriptyline—CYP2C9—endocrine gland—brain cancer	0.00021	0.00233	CbGeAlD
Nortriptyline—Urticaria—Temozolomide—brain cancer	0.000208	0.0018	CcSEcCtD
Nortriptyline—CHRM3—brain—brain cancer	0.000208	0.00232	CbGeAlD
Nortriptyline—HTR1A—brain—brain cancer	0.000207	0.00231	CbGeAlD
Nortriptyline—Abdominal pain—Temozolomide—brain cancer	0.000207	0.0018	CcSEcCtD
Nortriptyline—Body temperature increased—Temozolomide—brain cancer	0.000207	0.0018	CcSEcCtD
Nortriptyline—HRH1—endocrine gland—brain cancer	0.000207	0.0023	CbGeAlD
Nortriptyline—SLC6A2—brain—brain cancer	0.000206	0.00229	CbGeAlD
Nortriptyline—Thrombocytopenia—Etoposide—brain cancer	0.000206	0.00178	CcSEcCtD
Nortriptyline—Tachycardia—Etoposide—brain cancer	0.000205	0.00177	CcSEcCtD
Nortriptyline—HRH1—head—brain cancer	0.000204	0.00227	CbGeAlD
Nortriptyline—Hyperhidrosis—Etoposide—brain cancer	0.000203	0.00176	CcSEcCtD
Nortriptyline—Anorexia—Etoposide—brain cancer	0.0002	0.00173	CcSEcCtD
Nortriptyline—Hypersensitivity—Carmustine—brain cancer	0.0002	0.00173	CcSEcCtD
Nortriptyline—Nausea—Hydroxyurea—brain cancer	0.0002	0.00173	CcSEcCtD
Nortriptyline—CYP2E1—endocrine gland—brain cancer	0.000199	0.00221	CbGeAlD
Nortriptyline—HTR2A—midbrain—brain cancer	0.000197	0.00219	CbGeAlD
Nortriptyline—CYP2E1—head—brain cancer	0.000196	0.00218	CbGeAlD
Nortriptyline—Hypotension—Etoposide—brain cancer	0.000196	0.0017	CcSEcCtD
Nortriptyline—Asthenia—Carmustine—brain cancer	0.000195	0.00169	CcSEcCtD
Nortriptyline—Hypersensitivity—Temozolomide—brain cancer	0.000193	0.00167	CcSEcCtD
Nortriptyline—HTR2A—spinal cord—brain cancer	0.000192	0.00213	CbGeAlD
Nortriptyline—PTGS1—endocrine gland—brain cancer	0.000192	0.00213	CbGeAlD
Nortriptyline—ADRA1A—brain—brain cancer	0.000191	0.00213	CbGeAlD
Nortriptyline—PTGS1—head—brain cancer	0.000189	0.0021	CbGeAlD
Nortriptyline—Paraesthesia—Etoposide—brain cancer	0.000189	0.00163	CcSEcCtD
Nortriptyline—Asthenia—Temozolomide—brain cancer	0.000188	0.00163	CcSEcCtD
Nortriptyline—DRD2—brain—brain cancer	0.000187	0.00208	CbGeAlD
Nortriptyline—Somnolence—Etoposide—brain cancer	0.000187	0.00162	CcSEcCtD
Nortriptyline—HRH1—central nervous system—brain cancer	0.000186	0.00207	CbGeAlD
Nortriptyline—Diarrhoea—Carmustine—brain cancer	0.000186	0.00161	CcSEcCtD
Nortriptyline—Pruritus—Temozolomide—brain cancer	0.000186	0.00161	CcSEcCtD
Nortriptyline—Decreased appetite—Etoposide—brain cancer	0.000183	0.00158	CcSEcCtD
Nortriptyline—Fatigue—Etoposide—brain cancer	0.000181	0.00157	CcSEcCtD
Nortriptyline—Dizziness—Carmustine—brain cancer	0.00018	0.00155	CcSEcCtD
Nortriptyline—Constipation—Etoposide—brain cancer	0.00018	0.00155	CcSEcCtD
Nortriptyline—Diarrhoea—Temozolomide—brain cancer	0.00018	0.00155	CcSEcCtD
Nortriptyline—CYP2E1—central nervous system—brain cancer	0.000179	0.00199	CbGeAlD
Nortriptyline—CYP2E1—cerebellum—brain cancer	0.000175	0.00195	CbGeAlD
Nortriptyline—Dizziness—Temozolomide—brain cancer	0.000174	0.0015	CcSEcCtD
Nortriptyline—Feeling abnormal—Etoposide—brain cancer	0.000173	0.0015	CcSEcCtD
Nortriptyline—HTR2A—endocrine gland—brain cancer	0.000173	0.00192	CbGeAlD
Nortriptyline—Vomiting—Carmustine—brain cancer	0.000173	0.00149	CcSEcCtD
Nortriptyline—PTGS1—central nervous system—brain cancer	0.000173	0.00192	CbGeAlD
Nortriptyline—Rash—Carmustine—brain cancer	0.000171	0.00148	CcSEcCtD
Nortriptyline—Dermatitis—Carmustine—brain cancer	0.000171	0.00148	CcSEcCtD
Nortriptyline—HTR2A—head—brain cancer	0.000171	0.0019	CbGeAlD
Nortriptyline—Headache—Carmustine—brain cancer	0.00017	0.00147	CcSEcCtD
Nortriptyline—Vomiting—Temozolomide—brain cancer	0.000167	0.00144	CcSEcCtD
Nortriptyline—Urticaria—Etoposide—brain cancer	0.000167	0.00144	CcSEcCtD
Nortriptyline—Abdominal pain—Etoposide—brain cancer	0.000166	0.00144	CcSEcCtD
Nortriptyline—Body temperature increased—Etoposide—brain cancer	0.000166	0.00144	CcSEcCtD
Nortriptyline—Rash—Temozolomide—brain cancer	0.000165	0.00143	CcSEcCtD
Nortriptyline—Dermatitis—Temozolomide—brain cancer	0.000165	0.00143	CcSEcCtD
Nortriptyline—Headache—Temozolomide—brain cancer	0.000164	0.00142	CcSEcCtD
Nortriptyline—Nausea—Carmustine—brain cancer	0.000161	0.0014	CcSEcCtD
Nortriptyline—CYP3A4—endocrine gland—brain cancer	0.00016	0.00178	CbGeAlD
Nortriptyline—CYP2D6—endocrine gland—brain cancer	0.000157	0.00175	CbGeAlD
Nortriptyline—Nausea—Temozolomide—brain cancer	0.000156	0.00135	CcSEcCtD
Nortriptyline—HTR2A—central nervous system—brain cancer	0.000156	0.00173	CbGeAlD
Nortriptyline—CYP2D6—head—brain cancer	0.000155	0.00173	CbGeAlD
Nortriptyline—Hypersensitivity—Etoposide—brain cancer	0.000155	0.00134	CcSEcCtD
Nortriptyline—HTR2A—cerebellum—brain cancer	0.000152	0.00169	CbGeAlD
Nortriptyline—Asthenia—Etoposide—brain cancer	0.000151	0.0013	CcSEcCtD
Nortriptyline—Pruritus—Etoposide—brain cancer	0.000149	0.00129	CcSEcCtD
Nortriptyline—HRH1—brain—brain cancer	0.000148	0.00165	CbGeAlD
Nortriptyline—CYP3A4—central nervous system—brain cancer	0.000144	0.0016	CbGeAlD
Nortriptyline—Diarrhoea—Etoposide—brain cancer	0.000144	0.00124	CcSEcCtD
Nortriptyline—CYP2E1—brain—brain cancer	0.000142	0.00158	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—brain cancer	0.000142	0.00158	CbGeAlD
Nortriptyline—Dizziness—Etoposide—brain cancer	0.000139	0.0012	CcSEcCtD
Nortriptyline—CYP2D6—cerebellum—brain cancer	0.000139	0.00154	CbGeAlD
Nortriptyline—PTGS1—brain—brain cancer	0.000137	0.00152	CbGeAlD
Nortriptyline—Vomiting—Etoposide—brain cancer	0.000134	0.00116	CcSEcCtD
Nortriptyline—Rash—Etoposide—brain cancer	0.000132	0.00115	CcSEcCtD
Nortriptyline—Dermatitis—Etoposide—brain cancer	0.000132	0.00115	CcSEcCtD
Nortriptyline—Headache—Etoposide—brain cancer	0.000132	0.00114	CcSEcCtD
Nortriptyline—Nausea—Etoposide—brain cancer	0.000125	0.00108	CcSEcCtD
Nortriptyline—HTR2A—brain—brain cancer	0.000124	0.00137	CbGeAlD
Nortriptyline—CYP2D6—brain—brain cancer	0.000113	0.00125	CbGeAlD
Nortriptyline—Trimipramine—CYP2C9—brain cancer	0.000101	0.372	CrCbGaD
Nortriptyline—Doxepin—CYP2C9—brain cancer	9.62e-05	0.354	CrCbGaD
Nortriptyline—Amitriptyline—CYP2C9—brain cancer	7.44e-05	0.274	CrCbGaD
Nortriptyline—HTR2C—Signaling Pathways—PDGFRA—brain cancer	8.12e-06	0.000148	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PIK3CG—brain cancer	8.07e-06	0.000147	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—APC—brain cancer	8.07e-06	0.000147	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SPP1—brain cancer	7.93e-06	0.000145	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—IL2—brain cancer	7.91e-06	0.000144	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SPP1—brain cancer	7.89e-06	0.000144	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—EGFR—brain cancer	7.79e-06	0.000142	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	7.78e-06	0.000142	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CG—brain cancer	7.73e-06	0.000141	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—APC—brain cancer	7.73e-06	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SPP1—brain cancer	7.55e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL2—brain cancer	7.54e-06	0.000138	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HES1—brain cancer	7.53e-06	0.000137	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL2—brain cancer	7.5e-06	0.000137	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HES1—brain cancer	7.41e-06	0.000135	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HES1—brain cancer	7.39e-06	0.000135	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.38e-06	0.000135	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HES1—brain cancer	7.37e-06	0.000134	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—EGFR—brain cancer	7.35e-06	0.000134	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HES1—brain cancer	7.35e-06	0.000134	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CG—brain cancer	7.31e-06	0.000133	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—IL2—brain cancer	7.29e-06	0.000133	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HES1—brain cancer	7.27e-06	0.000133	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—APC—brain cancer	7.26e-06	0.000133	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	7.26e-06	0.000133	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HES1—brain cancer	7.25e-06	0.000132	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL2—brain cancer	7.18e-06	0.000131	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—IL2—brain cancer	7.17e-06	0.000131	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PDGFRA—brain cancer	7.17e-06	0.000131	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IRS2—brain cancer	7.17e-06	0.000131	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ENO2—brain cancer	7.16e-06	0.000131	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—IL2—brain cancer	7.16e-06	0.000131	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—IL2—brain cancer	7.14e-06	0.00013	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IRS2—brain cancer	7.13e-06	0.00013	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—IL2—brain cancer	7.11e-06	0.00013	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PDGFRA—brain cancer	7.05e-06	0.000129	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—IL2—brain cancer	7.04e-06	0.000129	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—brain cancer	7.04e-06	0.000128	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.04e-06	0.000128	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—IL2—brain cancer	7.03e-06	0.000128	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PDGFRA—brain cancer	7.02e-06	0.000128	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PDGFRA—brain cancer	6.99e-06	0.000128	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—IDH1—brain cancer	6.99e-06	0.000128	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SPP1—brain cancer	6.96e-06	0.000127	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—brain cancer	6.93e-06	0.000126	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PDGFRA—brain cancer	6.93e-06	0.000126	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	6.91e-06	0.000126	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SPP1—brain cancer	6.85e-06	0.000125	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SPP1—brain cancer	6.83e-06	0.000125	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IRS2—brain cancer	6.83e-06	0.000125	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SPP1—brain cancer	6.81e-06	0.000124	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SPP1—brain cancer	6.79e-06	0.000124	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SPP1—brain cancer	6.72e-06	0.000123	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SPP1—brain cancer	6.71e-06	0.000122	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—RELA—brain cancer	6.68e-06	0.000122	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—ERBB2—brain cancer	6.64e-06	0.000121	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL2—brain cancer	6.62e-06	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—brain cancer	6.62e-06	0.000121	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL2—brain cancer	6.52e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL2—brain cancer	6.5e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CG—brain cancer	6.49e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL2—brain cancer	6.48e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL2—brain cancer	6.46e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL2—brain cancer	6.4e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL2—brain cancer	6.38e-06	0.000116	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APC—brain cancer	6.33e-06	0.000116	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6.33e-06	0.000116	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—RELA—brain cancer	6.3e-06	0.000115	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APC—brain cancer	6.3e-06	0.000115	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CG—brain cancer	6.3e-06	0.000115	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS2—brain cancer	6.29e-06	0.000115	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—ERBB2—brain cancer	6.26e-06	0.000114	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS2—brain cancer	6.19e-06	0.000113	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS2—brain cancer	6.18e-06	0.000113	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS2—brain cancer	6.16e-06	0.000112	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS2—brain cancer	6.14e-06	0.000112	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS2—brain cancer	6.08e-06	0.000111	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS2—brain cancer	6.06e-06	0.000111	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—RELA—brain cancer	6.04e-06	0.00011	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	6.03e-06	0.00011	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APC—brain cancer	6.03e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL2—brain cancer	6.02e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ERBB2—brain cancer	6e-06	0.000109	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCND1—brain cancer	5.87e-06	0.000107	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CTNNB1—brain cancer	5.81e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.77e-06	0.000105	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—brain cancer	5.74e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—brain cancer	5.68e-06	0.000104	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—RELA—brain cancer	5.68e-06	0.000104	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ERBB2—brain cancer	5.64e-06	0.000103	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APC—brain cancer	5.56e-06	0.000101	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CG—brain cancer	5.56e-06	0.000101	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCND1—brain cancer	5.53e-06	0.000101	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ENO2—brain cancer	5.53e-06	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—brain cancer	5.49e-06	0.0001	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CTNNB1—brain cancer	5.48e-06	0.0001	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CG—brain cancer	5.47e-06	9.98e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APC—brain cancer	5.47e-06	9.98e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CG—brain cancer	5.46e-06	9.97e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APC—brain cancer	5.46e-06	9.96e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.46e-06	9.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CG—brain cancer	5.45e-06	9.95e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CG—brain cancer	5.44e-06	9.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APC—brain cancer	5.44e-06	9.93e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—brain cancer	5.44e-06	9.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CG—brain cancer	5.42e-06	9.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APC—brain cancer	5.42e-06	9.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CG—brain cancer	5.37e-06	9.8e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APC—brain cancer	5.37e-06	9.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	5.36e-06	9.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APC—brain cancer	5.36e-06	9.77e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCND1—brain cancer	5.3e-06	9.67e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CTNNB1—brain cancer	5.25e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—brain cancer	5.23e-06	9.55e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—brain cancer	5.12e-06	9.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—brain cancer	5.11e-06	9.33e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—STAT3—brain cancer	5.06e-06	9.24e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—brain cancer	5.06e-06	9.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCND1—brain cancer	4.98e-06	9.09e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—brain cancer	4.98e-06	9.09e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—brain cancer	4.97e-06	9.07e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—brain cancer	4.96e-06	9.04e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—RELA—brain cancer	4.95e-06	9.03e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—brain cancer	4.94e-06	9.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	4.93e-06	9.01e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—RELA—brain cancer	4.92e-06	8.98e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.92e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—brain cancer	4.89e-06	8.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ERBB2—brain cancer	4.89e-06	8.92e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—brain cancer	4.88e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—brain cancer	4.83e-06	8.81e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—STAT3—brain cancer	4.78e-06	8.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—RELA—brain cancer	4.71e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MYC—brain cancer	4.71e-06	8.59e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CG—brain cancer	4.7e-06	8.57e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ERBB2—brain cancer	4.68e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—brain cancer	4.62e-06	8.43e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—brain cancer	4.6e-06	8.4e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—brain cancer	4.58e-06	8.35e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—brain cancer	4.46e-06	8.13e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MYC—brain cancer	4.44e-06	8.1e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—brain cancer	4.43e-06	8.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—brain cancer	4.34e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RELA—brain cancer	4.34e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCND1—brain cancer	4.34e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—brain cancer	4.34e-06	7.92e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCND1—brain cancer	4.32e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ERBB2—brain cancer	4.32e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—brain cancer	4.3e-06	7.85e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.3e-06	7.85e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CTNNB1—brain cancer	4.28e-06	7.81e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RELA—brain cancer	4.27e-06	7.8e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RELA—brain cancer	4.26e-06	7.78e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—brain cancer	4.25e-06	7.76e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RELA—brain cancer	4.25e-06	7.76e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.25e-06	7.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—brain cancer	4.24e-06	7.74e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ERBB2—brain cancer	4.24e-06	7.73e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RELA—brain cancer	4.24e-06	7.73e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ERBB2—brain cancer	4.22e-06	7.71e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CG—brain cancer	4.22e-06	7.69e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ERBB2—brain cancer	4.21e-06	7.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RELA—brain cancer	4.2e-06	7.66e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RELA—brain cancer	4.18e-06	7.64e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.17e-06	7.61e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—brain cancer	4.16e-06	7.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.16e-06	7.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.14e-06	7.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.1e-06	7.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—brain cancer	4e-06	7.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—brain cancer	3.91e-06	7.14e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—brain cancer	3.91e-06	7.13e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CG—brain cancer	3.88e-06	7.08e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—brain cancer	3.86e-06	7.05e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—brain cancer	3.85e-06	7.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CG—brain cancer	3.84e-06	7.02e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—brain cancer	3.84e-06	7.01e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—brain cancer	3.83e-06	6.99e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—brain cancer	3.82e-06	6.96e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCND1—brain cancer	3.81e-06	6.96e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.79e-06	6.91e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—brain cancer	3.78e-06	6.9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.78e-06	6.89e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—brain cancer	3.77e-06	6.88e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—brain cancer	3.77e-06	6.87e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCND1—brain cancer	3.75e-06	6.85e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—brain cancer	3.75e-06	6.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCND1—brain cancer	3.74e-06	6.83e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCND1—brain cancer	3.73e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—brain cancer	3.73e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—brain cancer	3.72e-06	6.79e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.72e-06	6.78e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.71e-06	6.77e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CTNNB1—brain cancer	3.7e-06	6.74e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—brain cancer	3.68e-06	6.72e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CTNNB1—brain cancer	3.68e-06	6.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.67e-06	6.7e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.65e-06	6.66e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—brain cancer	3.65e-06	6.65e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.64e-06	6.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—brain cancer	3.61e-06	6.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—brain cancer	3.57e-06	6.52e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—brain cancer	3.49e-06	6.37e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—brain cancer	3.48e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—brain cancer	3.47e-06	6.32e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—brain cancer	3.41e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—brain cancer	3.39e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—brain cancer	3.32e-06	6.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—brain cancer	3.32e-06	6.05e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—brain cancer	3.29e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—brain cancer	3.29e-06	5.99e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—brain cancer	3.28e-06	5.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.27e-06	5.97e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—brain cancer	3.26e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.25e-06	5.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.24e-06	5.92e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—brain cancer	3.24e-06	5.92e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—brain cancer	3.24e-06	5.91e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—brain cancer	3.23e-06	5.9e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—brain cancer	3.22e-06	5.88e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.21e-06	5.86e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—brain cancer	3.21e-06	5.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.2e-06	5.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—brain cancer	3.18e-06	5.8e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.17e-06	5.79e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—brain cancer	3.06e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—brain cancer	3.01e-06	5.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—brain cancer	3e-06	5.48e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—brain cancer	2.99e-06	5.46e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—brain cancer	2.99e-06	5.46e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—brain cancer	2.98e-06	5.45e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—brain cancer	2.95e-06	5.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—brain cancer	2.95e-06	5.38e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—brain cancer	2.94e-06	5.37e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—brain cancer	2.94e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—brain cancer	2.93e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—brain cancer	2.92e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—brain cancer	2.89e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.88e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—brain cancer	2.86e-06	5.22e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—brain cancer	2.85e-06	5.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—brain cancer	2.72e-06	4.97e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—brain cancer	2.54e-06	4.63e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—brain cancer	2.51e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—brain cancer	2.47e-06	4.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—brain cancer	2.47e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—brain cancer	2.46e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—brain cancer	2.45e-06	4.47e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—brain cancer	2.43e-06	4.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—brain cancer	2.42e-06	4.42e-05	CbGpPWpGaD
